Study analyzes role of PARP enzyme in eukaryotes

Mar 08, 2011
Ohio State University’s Rebecca S. Lamb, Ph.D., co-authored a recent paper that used Ohio Supercomputer Center resources to conduct a phylogenetic analysis of a superfamily of enzymes implicated in a wide range of human diseases and important targets for anti-cancer therapies. Credit: Lamb/OSU

An Ohio State University molecular biologist leveraged a supercomputer to help better define the family tree of a group of enzymes that have been implicated in a wide range of human diseases and are important targets for anti-cancer therapies.

Along with several OSU colleagues, Rebecca S. Lamb, Ph.D., an assistant professor of , recently analyzed the of the poly(ADP-ribose) (PARP) superfamily.

These proteins are found in eukaryotes, a wide range of organisms – animals, plants, molds, fungi, algae and protozoa –whose cells contain complex structures enclosed within membranes. While PARP proteins can be found with any of these "supergroups," they have been most extensively studied in mammals.

"In these organisms, PARPs have key functions in DNA repair, genome integrity and epigenetic regulation," said Lamb. "More recently it has been found that proteins within the PARP superfamily have a broader range of functions that initially predicted."

The researchers used computers to identify 236 PARP proteins from 77 species across five of the six supergroups. Lamb then accessed the Glen Cluster at the Ohio Center (OSC) to perform extensive phylogenetic analyses of the identified PARP regions.

"This is computationally intensive work that would have been impossible without the computer resources provided at OSC," Lamb said. "In particular, the ability to try a variety of tools that require a great deal of CPU and memory capabilities was essential for success."

Amongst other tools, she employed the PhyML3.0 software package, which fit a statistical model to the aligned sequence data and provided estimates for the model's parameters.

"Dr. Lamb's project is an excellent example of a scientist running a very domain-specific software package on our state-of-the-art systems," said Ashok Krishnamurthy, Ph.D., interim co-executive director of OSC. "While the center maintains a large collection of licensed and open-source software, there are occasions where very specialized or customized applications are required. Our staff members are very good at working with researchers to modify these codes to get them installed, running and delivering results."

Access to powerful OSC systems allowed the researchers to experiment with a wide variety of options and parameters, in order to achieve the best results, Lamb noted.

"PARPs are found in all eukaryotic supergroups for which sequence is available, but some individual lineages within supergroups have independently lost these genes," said Lamb. "The PARP superfamily can be subdivided into six branches or 'clades.' Two of these clades were likely found in the last common eukaryotic ancestor. In addition, we have identified PARPs in organisms in which they have not previously been described."

Three main conclusions were drawn from the study. First, the broad distribution and pattern of representation of PARP genes indicated to the researchers that the ancestor of all existing eukaryotes encoded proteins of this type. Second, the ancestral PARP proteins had different functions and activities. One of these proteins likely functioned in DNA damage response. Third, the diversity of the PARP superfamily is larger than previously documented, suggesting as more eukaryotic genomes become available, this gene family will grow in both number and type.

Explore further: Tarantula toxin is used to report on electrical activity in live cells

More information: The study, "Evolutionary history of the poly(ADP-ribose) polymerase gene family in eukaryotes," appeared in a recent issue of the journal BMC Evolutionary Biology.

Provided by Ohio Supercomputer Center

4.5 /5 (2 votes)

Related Stories

Synthetic lethality: A new way to kill cancer cells

Feb 22, 2010

Ovarian and breast cancer treatments being developed that mix a protein inhibitor and traditional anticancer drugs are showing signs of success, according to a new review for Faculty of 1000 Biology Reports.

New test for ovarian cancer patients

Nov 09, 2010

Scientists have developed a new test to select which patients with ovarian cancer will benefit from new drugs called PARP inhibitors, according to research presented at the National Cancer Research Institute ...

Recommended for you

Scientists see how plants optimize their repair

10 hours ago

Researchers led by a Washington State University biologist have found the optimal mechanism by which plants heal the botanical equivalent of a bad sunburn. Their work, published in the Proceedings of the Na ...

Structure of an iron-transport protein revealed

16 hours ago

For the first time, the three dimensional structure of the protein that is essential for iron import into cells, has been elucidated. Biochemists of the University of Zurich have paved the way towards a better ...

Over-organizing repair cells set the stage for fibrosis

17 hours ago

The excessive activity of repair cells in the early stages of tissue recovery sets the stage for fibrosis by priming the activation of an important growth factor, according to a study in The Journal of Ce ...

User comments : 0